-
Following the two consecutive boards, this pharmaceutical stock has opened the limit again!
Time of Update: 2022-10-12
The actual controllers of the Company, Yu Chunming and Yu Chaobiao, have signed the Share Transfer Agreement on Anhui Huangshan Capsule Co.
The actual controllers of the Company, Yu Chunming and Yu Chaobiao, have signed the Share Transfer Agreement on Anhui Huangshan Capsule Co.
-
The Ministry of Industry and Information Technology will carry out the action of strengthening the chain of the pharmaceutical industry chain
Time of Update: 2022-10-02
Zhou Jian, deputy director of the Department of Consumer Goods Industry of the Ministry of Industry and Information Technology, said on the 14th that it will carry out the action of strengthening the chain of the pharmaceutical industry chain, focus on weak links, support upstream and downstream enterprises in the industrial chain to carry out collaborative research, and continue to enhance key core competitiveness.
-
New crown oral drugs and a variety of rare disease drugs passed the 2022 medical insurance catalogue adjustment review
Time of Update: 2022-10-02
From September 6 to 12, 2022, our bureau announced to the public the "List of Declared Drugs Approved by the Preliminary Form Examination of the Adjustment of the National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance Drug Catalogue in 2022".
-
Notice of the State Food and Drug Administration on 17 batches of drugs that do not meet the regulations
Time of Update: 2022-10-02
, Ltd. did not meet the regulations, and the items that did not meet the requirements were prohibited pesticide residues 。 After inspection by Gansu Provincial Drug Inspection and Research Institute, 1 batch of madder marked as produced by Sichuan Yuanshang Herb Chinese Medicine Tablet Co.
-
Domestic pharmaceutical innovation is active Experts: Accelerate the speed of domestic innovative drugs to go to sea
Time of Update: 2022-10-02
(End) Disease tumor medicine and health enterprises Professor Jiang Jie, dean of the Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical and Medical Device Real-World Research Institute of Jinan University, recently said through video at the 2021 China Biomedical Enterprises Top 100 Innovative Strength Series List Conference that domestic pharmaceutical innovation is active, and favorable and negative policies guide and force enterprises to innovate.
-
Hainan: Repeal the "Implementation Measures for Rewarded Reporting on Food and Drug Safety in Hainan Province"
Time of Update: 2022-10-02
Medicines According to the news on the website of the People's Government of Hainan Province on the 18th, the General Office of the People's Government of Hainan Province recently issued a notice on the abolition of the "Implementation Measures for the Reward for Food and Drug Safety Reporting in Hainan Province".
-
Raw materials such as dogwood are rising, and the cost of Yibai Pharmaceutical is increasing!
Time of Update: 2022-10-02
Ginseng, the new production continues, this year's production area rains more, but the market supply of goods, the recent merchants small batch procurement, the source of goods moving around, the market is running stably, the price of 80 raw drying goods is between 255-260 yuan, and the price of raw sunning 45 is between 320-330 yuan.
-
Information on medical device licensing in each province (as of August 31, 2022)
Time of Update: 2022-10-01
In order to further meet the needs of enterprises and the public to inquire about medical device regulatory information and strengthen social supervision and social co-governance, the State Food and
-
Can this summer's drought in Gansu help the price of astragalus break through?
Time of Update: 2022-10-01
In the Gansu traditional Chinese medicine "troika" of angelica, ginseng, astragalus, astragalus price fluctuations are the most "gentle", are the annual use of more than 40,000 tons of varieties, why
-
Shanghai to build a high-quality medical service system: "top of the sky, strong waist, standing"
Time of Update: 2022-10-01
At the press conference of the special series of party committees held by the Shanghai Municipal Government on the 22nd, Wu Jinglei, deputy secretary and director of the party group of the Shanghai M
-
The State Food and Drug Administration released the conversion of pain relief capsules into over-the-counter drugs
Time of Update: 2022-10-01
Model instructions for over-the-counter drugs State Food and Drug Administration September 16, 2022 drugsAdministration of Drug Registrationenterprisesover-the-counter drugs serial number name of article Specifications (composition) classify remark 1 Pain Relief Capsules 0.
-
Shijiazhuang drug import port was approved to promote the development of the "100 billion-level" pharmaceutical industry cluster
Time of Update: 2022-10-01
(End) Pharmaceutical agency procurement enterprises The Information Office of the Hebei Provincial Government held a press conference on the construction of Shijiazhuang drug import port on the 22nd.
-
In some places, the regulations on setting thresholds for receiving maternity insurance have been suspended
Time of Update: 2022-10-01
Recently, Liang Hongxia, associate professor of the School of Administrative Law of Southwest University of Political Science and Law, received a phone call from the staff of the Legislative Affairs
-
The price of precious Chinese medicine raw materials has increased a lot, and the cost pressure of ConnBei has increased!
Time of Update: 2022-10-01
Zhejiang Kangenbei Pharmaceutical Co. , Ltd. (Kangenbei, SH 600572) released the 2022 semi-annual performance report on the evening of August 24, showing that in the first half of 2022, the company's
-
Inner Mongolia "explores the bottom of Mongolian astragalus and other high-quality medicinal resources"
Time of Update: 2022-10-01
(End) The reporter learned from the Hohhot Comprehensive Experimental Station of the National Chinese Medicinal Materials Industry Technology System on the 20th that as of now, the station has completed the research activities of "Research on the Selection and Breeding of High-quality Germplasm of Chinese and Mongolian Medicinal Materials in the Hetao Region" in the autumn of 2022, especially for a number of high-quality medicinal materials resources such as Mongolian astragalus and goji berries.
-
Write the nation's first prescription! The "life-saving drug" Chlorbachan landed
Time of Update: 2022-10-01
With the efforts of the National Health Commission, the State Food and Drug Administration and other parties, on September 22, Chlorbazhan, once known as a "life-saving drug" as a temporary import of drugs in urgent clinical need, issued the country's first prescription at Peking Union Medical College Hospital.
-
Pfizer submitted an application to the FDA for an upgraded vaccine for people aged 5 to 11 years
Time of Update: 2022-10-01
(End) Pfizer submitted an application authorization to the US Food and Drug Administration (FDA) on the 26th local time for the vaccination of Pfizer upgraded version of the new crown vaccine for groups aged 5 to 11.
-
Review: Online sales of prescription drugs can not make prescription rules "discounted"
Time of Update: 2022-10-01
There is still a long way to go to improve the operation and supervision rules of online prescription drugs, and the basic bottom line that should be kept at present is not to let some good practices of physical medical institutions managing prescription drugs be "discounted" and implemented.
-
The Melimus-coated coronary balloon dilation catheter was approved for marketing
Time of Update: 2022-10-01
Recently, the State Drug Administration approved the registration of the innovative product "Umimos Coated Coronary Balloon Expansion Catheter" produced by Shandong Jiwei Medical Products Co.
Recently, the State Drug Administration approved the registration of the innovative product "Umimos Coated Coronary Balloon Expansion Catheter" produced by Shandong Jiwei Medical Products Co.
-
The eighth batch of 42 injections is poised for 60 billion yuan The market is rising
Time of Update: 2022-10-01
Among the evaluated injections that have not been included in the national collection, 42 (in generic terms) have met the competitive conditions of 4 or more (26 up to 5 or more), and the total terminal sales scale of China's public medical institutions will exceed 60 billion yuan in 2021, with Kelun Pharmaceutical, Beite Pharmaceutical, Yangzijiang, etc.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
